000819525 001__ 819525
000819525 005__ 20220930130107.0
000819525 0247_ $$2doi$$a10.3233/JAD-160253
000819525 0247_ $$2ISSN$$a1387-2877
000819525 0247_ $$2ISSN$$a1875-8908
000819525 0247_ $$2WOS$$aWOS:000383838400007
000819525 0247_ $$2altmetric$$aaltmetric:10288350
000819525 0247_ $$2pmid$$apmid:27472876
000819525 037__ $$aFZJ-2016-05168
000819525 041__ $$aEnglish
000819525 082__ $$a610
000819525 1001_ $$0P:(DE-Juel1)145968$$aHülsemann, Maren$$b0
000819525 245__ $$aBiofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer’s Disease
000819525 260__ $$aAmsterdam$$bIOS Press$$c2016
000819525 3367_ $$2DRIVER$$aarticle
000819525 3367_ $$2DataCite$$aOutput Types/Journal article
000819525 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1476713079_20902
000819525 3367_ $$2BibTeX$$aARTICLE
000819525 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000819525 3367_ $$00$$2EndNote$$aJournal Article
000819525 520__ $$aAmyloid-β (Aβ) oligomers represent a promising biomarker for the early diagnosis of Alzheimer’s disease (AD). However, state-of-the-art methods for immunodetection of Aβ oligomers in body fluids show a large variability and lack a reliable and stable standard that enables the reproducible quantitation of Aβ oligomers. At present, the only available standard applied in these assays is based on a random aggregation process of synthetic Aβ and has neither a defined size nor a known number of epitopes. In this report, we generated a highly stable standard in the size range of native Aβ oligomers that exposes a defined number of epitopes. The standard consists of a silica nanoparticle (SiNaP), which is functionalized with Aβ peptides on its surface (Aβ-SiNaP). The different steps of Aβ-SiNaP synthesis were followed by microscopic, spectroscopic and biochemical analyses. To investigate the performance of Aβ-SiNaPs as an appropriate standard in Aβ oligomer immunodetection, Aβ-SiNaPs were diluted in cerebrospinal fluid and quantified down to a concentration of 10 fM in the sFIDA (surface-based fluorescence intensity distribution analysis) assay. This detection limit corresponds to an Aβ concentration of 1.9 ng l–1 and lies in the sensitivity range of currently applied diagnostic tools based on Aβ oligomer quantitation. Thus, we developed a highly stable and well-characterized standard for the application in Aβ oligomer immunodetection assays that finally allows the reproducible quantitation of Aβ oligomers down to single molecule level and provides a fundamental improvement for the worldwide standardization process of diagnostic methods in AD research.
000819525 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000819525 588__ $$aDataset connected to CrossRef
000819525 7001_ $$0P:(DE-Juel1)162137$$aZafiu, Christian$$b1
000819525 7001_ $$0P:(DE-Juel1)145440$$aKühbach, Katja$$b2
000819525 7001_ $$0P:(DE-Juel1)144193$$aLühmann, Nicole$$b3
000819525 7001_ $$0P:(DE-Juel1)159122$$aHerrmann, Yvonne$$b4
000819525 7001_ $$0P:(DE-Juel1)145123$$aPeters, Luriano$$b5
000819525 7001_ $$0P:(DE-Juel1)145159$$aLinnartz, Christina$$b6
000819525 7001_ $$0P:(DE-Juel1)159192$$aWillbold, Johannes$$b7
000819525 7001_ $$0P:(DE-Juel1)136806$$aKravchenko, Kateryna$$b8
000819525 7001_ $$0P:(DE-Juel1)162310$$aKulawik, Andreas$$b9
000819525 7001_ $$0P:(DE-Juel1)133857$$aWillbold, Sabine$$b10
000819525 7001_ $$0P:(DE-Juel1)157832$$aBannach, Oliver$$b11
000819525 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b12$$eCorresponding author
000819525 773__ $$0PERI:(DE-600)2070772-1$$a10.3233/JAD-160253$$gVol. 54, no. 1, p. 79 - 88$$n1$$p79 - 88$$tJournal of Alzheimer's disease$$v54$$x1875-8908$$y2016
000819525 8564_ $$uhttps://juser.fz-juelich.de/record/819525/files/Biofunctionalized%20Silica%20Nanoparticles%3A%20Standards%20in%20Amyloid-%CE%B2%20Oligomer-Based%20Diagnosis%20of%20Alzheimer%E2%80%99s%20Disease_2016.pdf$$yRestricted
000819525 8564_ $$uhttps://juser.fz-juelich.de/record/819525/files/Biofunctionalized%20Silica%20Nanoparticles%3A%20Standards%20in%20Amyloid-%CE%B2%20Oligomer-Based%20Diagnosis%20of%20Alzheimer%E2%80%99s%20Disease_2016.pdf?subformat=pdfa$$xpdfa$$yRestricted
000819525 8767_ $$92016-06-06$$d2016-06-06$$ePublication charges$$jZahlung erfolgt$$lKK: Mittermaier$$p16-0253R2
000819525 909CO $$ooai:juser.fz-juelich.de:819525$$pOpenAPC$$pVDB$$popenCost
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)162137$$aForschungszentrum Jülich$$b1$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145440$$aForschungszentrum Jülich$$b2$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144193$$aForschungszentrum Jülich$$b3$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159122$$aForschungszentrum Jülich$$b4$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145123$$aForschungszentrum Jülich$$b5$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145159$$aForschungszentrum Jülich$$b6$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159192$$aForschungszentrum Jülich$$b7$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)162310$$aForschungszentrum Jülich$$b9$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133857$$aForschungszentrum Jülich$$b10$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)157832$$aForschungszentrum Jülich$$b11$$kFZJ
000819525 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b12$$kFZJ
000819525 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000819525 9141_ $$y2016
000819525 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000819525 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000819525 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000819525 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ ALZHEIMERS DIS : 2015
000819525 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000819525 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000819525 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000819525 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000819525 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000819525 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000819525 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000819525 915__ $$0StatID:(DE-HGF)0550$$2StatID$$aNo Authors Fulltext
000819525 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000819525 920__ $$lyes
000819525 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000819525 9201_ $$0I:(DE-Juel1)ZEA-3-20090406$$kZEA-3$$lAnalytik$$x1
000819525 980__ $$ajournal
000819525 980__ $$aVDB
000819525 980__ $$aUNRESTRICTED
000819525 980__ $$aI:(DE-Juel1)ICS-6-20110106
000819525 980__ $$aI:(DE-Juel1)ZEA-3-20090406
000819525 980__ $$aAPC
000819525 981__ $$aI:(DE-Juel1)IBI-7-20200312
000819525 981__ $$aI:(DE-Juel1)ZEA-3-20090406